OptiBiotix Health plc
OPTBF
$0.11
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 107.88% | 69.48% | 39.45% | 12.34% | -13.69% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 107.88% | 69.48% | 39.45% | 12.34% | -13.69% |
| Cost of Revenue | 117.83% | 91.66% | 71.89% | 29.31% | -11.49% |
| Gross Profit | 97.09% | 46.26% | 6.63% | -5.00% | -15.95% |
| SG&A Expenses | 44.68% | 36.87% | 31.99% | 9.36% | -8.34% |
| Depreciation & Amortization | -126.44% | -166.67% | -40.00% | -93.84% | -92.77% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 51.41% | 43.10% | 37.87% | 13.60% | -6.51% |
| Operating Income | -35.36% | -34.45% | -37.26% | -14.03% | 4.24% |
| Income Before Tax | 91.25% | 58.83% | 7.43% | 66.62% | 76.04% |
| Income Tax Expenses | -1,394.12% | -1,413.73% | -1,502.04% | 51.10% | 96.96% |
| Earnings from Continuing Operations | 93.26% | 61.20% | 10.37% | 66.76% | 75.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 93.26% | 61.20% | 10.37% | 66.76% | 75.82% |
| EBIT | -35.36% | -34.45% | -37.26% | -14.03% | 4.24% |
| EBITDA | -40.16% | -39.02% | -41.73% | -14.52% | 6.24% |
| EPS Basic | 93.98% | 61.34% | 12.68% | 68.43% | 77.37% |
| Normalized Basic EPS | -24.73% | -21.55% | -23.12% | -1.02% | 15.45% |
| EPS Diluted | 93.98% | 61.34% | 12.68% | 68.43% | 77.37% |
| Normalized Diluted EPS | -24.73% | -21.55% | -23.12% | -1.02% | 15.45% |
| Average Basic Shares Outstanding | 9.20% | 8.88% | 8.55% | 7.05% | 5.52% |
| Average Diluted Shares Outstanding | 9.20% | 8.88% | 8.55% | 7.05% | 5.52% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |